Title and Department
Assistant Professor of Medicine
Allergy, Pulmonary and Critical Care Medicine
Professional bio
Ciara Shaver, MD, PhD, is an Assistant Professor of Medicine at Vanderbilt University Medical Center in the Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine. Her growing basic and translational research program centers on mechanisms of acute lung injury with an emphasis on inflammation during critical illness and after lung transplantation.

Dr. Shaver's laboratory is focused on understanding the mechanisms of acute lung injury and the acute respiratory distress syndrome (ARDS). Her scientific approach combines data from multiple animal models of acute lung injury with translational data from patients with ARDS. Currently, Dr. Shaver's primary focus is to understand the inflammatory consequences of extracellular hemoglobin in the airspace, particularly focusing on the role of macrophage subpopulations in regulating immune responses in the lung. Her previous graduate work investigated the interactions between bacterial exotoxins and innate immune cells during acute bacterial pneumonia. Dr. Shaver’s clinical interest is in lung transplantation with a particular focus on the early postoperative events that predict long-term outcomes. She is currently funded by a K08 and a Parker B. Francis Fellowship in Pulmonary Research.

Dr. Shaver has repeatedly been recognized for her work. She received the Elliot V. Newman Prize for the best oral presentation and the award for best basic science poster at the Vanderbilt Research Forum. She also received two scholarships to attend the American Thoracic Society International Conference for her superior abstracts. She was awarded a Vanderbilt Faculty Research Scholars Award to support continuing development toward independence as a physician-scientist. She is excited to continue pursuing both basic science and translational studies with clear clinical applications.

Dr. Shaver subspecializes in the care of lung transplant recipients and patients with end stage lung disease who are seeking lung transplantation.